RecruitingPhase 2NCT04791579
Antibiotic Prophylaxis for Neurogenic Bladder Botox
Studying Infectious disease of the nervous system
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Alberta
- Intervention
- Ciprofloxacin(drug)
- Enrollment
- 160 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2025 – 2027
Study locations (1)
- University of Alberta, Edmonton, Alberta, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04791579 on ClinicalTrials.govOther trials for Infectious disease of the nervous system
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07485283Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and DementiaTor Biering-Sørensen
- RECRUITINGNANCT07535281Effect of Complete Suction-Induced Collapse of the Renal Collecting System at the End of RIRS on Early Postoperative OutcomesKangdong Sacred Heart Hospital
- RECRUITINGNANCT07307976The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes ZosterBeijing Tiantan Hospital
- RECRUITINGNANCT07370389The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes ZosterBeijing Tiantan Hospital
- RECRUITINGPHASE4NCT07225101Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine ProceduresUniversity of Michigan
- RECRUITINGNCT07296965Oral Microbiome in Carotid AtherosclerosisSemmelweis University Heart and Vascular Center
- RECRUITINGNANCT06585254tVNS in Long COVID-19Icahn School of Medicine at Mount Sinai
- ACTIVE NOT RECRUITINGNCT06609681Parkinson Disease: A Model of National Digital Interventions to Prevent or Slow a Rise of Non-CommunicableRoongrooj Bhidayasiri
See all trials for Infectious disease of the nervous system →